Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Report on a novel emerging class of highly potent benzimidazole NPS opioids: Chemical and in vitro functional characterization of isotonitazene
Peter Blanckaert, Annelies Cannaert, Katleen Van Uytfanghe, et al.
Drug Testing and Analysis (2019) Vol. 12, Iss. 4, pp. 422-430
Closed Access | Times Cited: 88

Showing 1-25 of 88 citing articles:

Clinical toxicity of nitazene detections in two Australian emergency department toxicosurveillance systems
Katherine Isoardi, Sam Alfred, Courtney Weber, et al.
Drug and Alcohol Review (2025)
Open Access | Times Cited: 6
Isotonitazene Quantitation and Metabolite Discovery in Authentic Forensic Casework
Alex J. Krotulski, Donna M Papsun, Sherri L. Kacinko, et al.
Journal of Analytical Toxicology (2020) Vol. 44, Iss. 6, pp. 521-530
Open Access | Times Cited: 98
Synthesis, Chemical Characterization, and μ-Opioid Receptor Activity Assessment of the Emerging Group of “Nitazene” 2-Benzylbenzimidazole Synthetic Opioids
Marthe M. Vandeputte, Katleen Van Uytfanghe, Nathan K. Layle, et al.
ACS Chemical Neuroscience (2021) Vol. 12, Iss. 7, pp. 1241-1251
Open Access | Times Cited: 96
DARK Classics in Chemical Neuroscience: Etonitazene and Related Benzimidazoles
István Ujváry, Rachel Christie, Michael Evans‐Brown, et al.
ACS Chemical Neuroscience (2021) Vol. 12, Iss. 7, pp. 1072-1092
Closed Access | Times Cited: 88
The Rise and Fall of Isotonitazene and Brorphine: Two Recent Stars in the Synthetic Opioid Firmament
Marthe M. Vandeputte, Alex J. Krotulski, Donna M Papsun, et al.
Journal of Analytical Toxicology (2021) Vol. 46, Iss. 2, pp. 115-121
Open Access | Times Cited: 57
Pharmacological evaluation and forensic case series of N-pyrrolidino etonitazene (etonitazepyne), a newly emerging 2-benzylbenzimidazole ‘nitazene’ synthetic opioid
Marthe M. Vandeputte, Alex J. Krotulski, Donna Walther, et al.
Archives of Toxicology (2022) Vol. 96, Iss. 6, pp. 1845-1863
Open Access | Times Cited: 50
Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2017–2020: A Review
Amanda L A Mohr, Barry K. Logan, Melissa F. Fogarty, et al.
Journal of Analytical Toxicology (2022) Vol. 46, Iss. 6, pp. e116-e185
Open Access | Times Cited: 46
Patterns and motivations of polysubstance use: a rapid review of the qualitative evidence
Michèle Boileau-Falardeau, Gisèle Contreras, Geneviève Gariépy, et al.
Health Promotion and Chronic Disease Prevention in Canada (2022) Vol. 42, Iss. 2, pp. 47-59
Open Access | Times Cited: 41
A Review on the Green Synthesis of Benzimidazole Derivatives and Their Pharmacological Activities
Mónica Nardi, Natividad Herrera Cano, Svilen P. Simeonov, et al.
Catalysts (2023) Vol. 13, Iss. 2, pp. 392-392
Open Access | Times Cited: 31
Old Drugs and New Challenges: A Narrative Review of Nitazenes
Joseph V. Pergolizzi, Robert B. Raffa, Jo Ann LeQuang, et al.
Cureus (2023)
Open Access | Times Cited: 30
Method development for the quantification of nine nitazene analogs and brorphine in Dried Blood Spots utilizing liquid chromatography – tandem mass spectrometry
Christina Ververi, Martina Galletto, Marta Massano, et al.
Journal of Pharmaceutical and Biomedical Analysis (2024) Vol. 241, pp. 115975-115975
Open Access | Times Cited: 10
In vitro structure–activity relationships and forensic case series of emerging 2-benzylbenzimidazole ‘nitazene’ opioids
Liam M. De Vrieze, Sara E. Walton, Eline Pottie, et al.
Archives of Toxicology (2024) Vol. 98, Iss. 9, pp. 2999-3018
Open Access | Times Cited: 10
LCMS Detection and Characterization of In Vitro Metabolites of Isotonitazene, a Targeted Strategy for Novel Psychoactive Substance Control in Camel Racing
Jahfar Nalakath, Rasik Puzhithinipra Rasik, Ahmed Kadry, et al.
Rapid Communications in Mass Spectrometry (2025) Vol. 39, Iss. 7
Closed Access | Times Cited: 1
UHPLC-MS/MS-based Analysis of 17 Nitazenes in Human Hair for Practical Forensic Casework with Simultaneous Separation of 6 Groups of Isomers
Guoqing Gao, Shuo Yang, Xin Wang, et al.
Journal of Pharmaceutical and Biomedical Analysis (2025) Vol. 257, pp. 116707-116707
Closed Access | Times Cited: 1
The UHPLC-MS/MS method for the determination of 26 synthetic benzimidazole opioids (nitazene analogs) with isomers separation
Olga Wachełko, Kaja Tusiewicz, Paweł Szpot, et al.
Journal of Pharmaceutical and Biomedical Analysis (2025) Vol. 260, pp. 116796-116796
Closed Access | Times Cited: 1
Characterization of Mass Spectrometry Fragmentation Patterns Under Electron‐Activated Dissociation (EAD) for Rapid Structure Identification of Nitazene Analogs
Cuimei Liu, Boxian Huang, Zhendong Hua, et al.
Rapid Communications in Mass Spectrometry (2025) Vol. 39, Iss. 12
Closed Access | Times Cited: 1
Isotonitazene: Fatal intoxication in three cases involving this unreported novel psychoactive substance in Switzerland
F. Mueller, Christian Bogdal, Bernhard Pfeiffer, et al.
Forensic Science International (2021) Vol. 320, pp. 110686-110686
Open Access | Times Cited: 53
A Forward-Thinking Approach to Addressing the New Synthetic Opioid 2-Benzylbenzimidazole Nitazene Analogs by Liquid Chromatography–Tandem Quadrupole Mass Spectrometry (LC–QQQ-MS)
Sara E. Walton, Alex J. Krotulski, Barry K. Logan
Journal of Analytical Toxicology (2021) Vol. 46, Iss. 3, pp. 221-231
Open Access | Times Cited: 45
Cannabinoid receptor activation potential of the next generation, generic ban evading OXIZID synthetic cannabinoid receptor agonists
Marie H. Deventer, Katleen Van Uytfanghe, Inge M. J. Vinckier, et al.
Drug Testing and Analysis (2022) Vol. 14, Iss. 9, pp. 1565-1575
Open Access | Times Cited: 30
Comparative neuropharmacology of structurally distinct non-fentanyl opioids that are appearing on recreational drug markets worldwide
Marthe M. Vandeputte, Meng-Hua M. Tsai, Li Chen, et al.
Drug and Alcohol Dependence (2023) Vol. 249, pp. 109939-109939
Closed Access | Times Cited: 22
Synthesis, characterization, and biological investigations of potentially bioactive heterocyclic compounds containing benzimidazole nucleus
R. Champa, K.A. Vishnumurthy, Yadav D. Bodke, et al.
Results in Chemistry (2023) Vol. 6, pp. 101018-101018
Open Access | Times Cited: 20
Non-fentanyl new synthetic opioids – An update
Jolanta B. Zawilska, Piotr Adamowicz, Marta Kurpeta, et al.
Forensic Science International (2023) Vol. 349, pp. 111775-111775
Closed Access | Times Cited: 20
Alkoxy chain length governs the potency of 2-benzylbenzimidazole ‘nitazene’ opioids associated with human overdose
Grant C. Glatfelter, Marthe M. Vandeputte, Li Chen, et al.
Psychopharmacology (2023) Vol. 240, Iss. 12, pp. 2573-2584
Closed Access | Times Cited: 18
Frontiers in Bacterial-Based Green Synthesized Nanoparticles (NPs): A Sustainable Strategy for Combating Infectious Plant Pathogens
Amjad Ali, Muhammad Aasım, Kübra Çelık, et al.
Biocatalysis and Agricultural Biotechnology (2024) Vol. 60, pp. 103293-103293
Closed Access | Times Cited: 6
Nitazene test strips: a laboratory evaluation
Liam M. De Vrieze, Christophe P. Stove, Marthe M. Vandeputte
Harm Reduction Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top